Deutsche Bank’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $986K | Buy |
17,822
+3,055
| +21% | +$145K | ﹤0.01% | 2185 |
|
|
2025
Q4 | $552K | Buy |
14,767
+2,341
| +19% | +$95.1K | ﹤0.01% | 2517 |
|
|
2025
Q3 | $503K | Buy |
12,426
+182
| +1% | +$6.01K | ﹤0.01% | 2537 |
|
|
2025
Q2 | $313K | Sell |
12,244
-2,488
| -17% | -$54.3K | ﹤0.01% | 2708 |
|
|
2025
Q1 | $315K | Sell |
14,732
-2,141
| -13% | -$47.9K | ﹤0.01% | 2725 |
|
|
2024
Q4 | $354K | Buy |
16,873
+8,032
| +91% | +$186K | ﹤0.01% | 2801 |
|
|
2024
Q3 | $199K | Sell |
8,841
-3,550
| -29% | -$68.5K | ﹤0.01% | 2928 |
|
|
2024
Q2 | $208K | Sell |
12,391
-336
| -3% | -$5.4K | ﹤0.01% | 2779 |
|
|
2024
Q1 | $165K | Sell |
12,727
-1,070
| -8% | -$12.8K | ﹤0.01% | 2935 |
|
|
2023
Q4 | $160K | Hold |
13,797
| – | – | ﹤0.01% | 2994 |
|
|
2023
Q3 | $176K | Sell |
13,797
-34
| -0.2% | -$482 | ﹤0.01% | 2863 |
|
|
2023
Q2 | $189K | Buy |
13,831
+369
| +3% | +$5.29K | ﹤0.01% | 2912 |
|
|
2023
Q1 | $206K | Buy |
13,462
+3,767
| +39% | +$57.6K | ﹤0.01% | 2985 |
|
|
2022
Q4 | $130K | Buy |
9,695
+184
| +2% | +$2.47K | ﹤0.01% | 3201 |
|
|
2022
Q3 | $127K | Sell |
9,511
-1,299
| -12% | -$22.4K | ﹤0.01% | 3194 |
|
|
2022
Q2 | $206K | Sell |
10,810
-1,422
| -12% | -$26.9K | ﹤0.01% | 3148 |
|
|
2022
Q1 | $244K | Sell |
12,232
-1,320
| -10% | -$26.7K | ﹤0.01% | 3146 |
|
|
2021
Q4 | $277K | Sell |
13,552
-801
| -6% | -$17.1K | ﹤0.01% | 3204 |
|
|
2021
Q3 | $309K | Buy |
14,353
+1,112
| +8% | +$26.8K | ﹤0.01% | 3326 |
|
|
2021
Q2 | $383K | Sell |
13,241
-947
| -7% | -$25.6K | ﹤0.01% | 3392 |
|
|
2021
Q1 | $346K | Sell |
14,188
-21,326
| -60% | -$482K | ﹤0.01% | 3330 |
|
|
2020
Q4 | $690K | Buy |
35,514
+3,940
| +12% | +$72.5K | ﹤0.01% | 2693 |
|
|
2020
Q3 | $549K | Buy |
31,574
+21,363
| +209% | +$456K | ﹤0.01% | 2588 |
|
|
2020
Q2 | $269K | Buy |
10,211
+2,953
| +41% | +$73.3K | ﹤0.01% | 2983 |
|
|
2020
Q1 | $176K | Sell |
7,258
-8,074
| -53% | -$197K | ﹤0.01% | 3012 |
|
|
2019
Q4 | $379K | Sell |
15,332
-5,914
| -28% | -$137K | ﹤0.01% | 2869 |
|
|
2019
Q3 | $451K | Sell |
21,246
-7,098
| -25% | -$194K | ﹤0.01% | 2729 |
|
|
2019
Q2 | $897K | Sell |
28,344
-35,424
| -56% | -$1.11M | ﹤0.01% | 2901 |
|
|
2019
Q1 | $2.1M | Sell |
63,768
-12,975
| -17% | -$404K | ﹤0.01% | 2471 |
|
|
2018
Q4 | $2.46M | Sell |
76,743
-23,310
| -23% | -$879K | ﹤0.01% | 2260 |
|
|
2018
Q3 | $4.29M | Buy |
100,053
+207
| +0.2% | +$9.78K | ﹤0.01% | 2313 |
|
|
2018
Q2 | $4.6M | Sell |
99,846
-16,368
| -14% | -$725K | ﹤0.01% | 2359 |
|
|
2018
Q1 | $4.61M | Buy |
116,214
+34,756
| +43% | +$1.29M | ﹤0.01% | 2285 |
|
|
2017
Q4 | $2.73M | Buy |
81,458
+25,231
| +45% | +$896K | ﹤0.01% | 2515 |
|
|
2017
Q3 | $2.08M | Sell |
56,227
-21,014
| -27% | -$789K | ﹤0.01% | 2509 |
|
|
2017
Q2 | $2.86M | Buy |
77,241
+24,946
| +48% | +$814K | ﹤0.01% | 2326 |
|
|
2017
Q1 | $1.47M | Sell |
52,295
-7,510
| -13% | -$212K | ﹤0.01% | 2425 |
|
|
2016
Q4 | $1.75M | Sell |
59,805
-31,987
| -35% | -$873K | ﹤0.01% | 2342 |
|
|
2016
Q3 | $2.49M | Buy |
91,792
+3,891
| +4% | +$88K | ﹤0.01% | 2197 |
|
|
2016
Q2 | $1.64M | Sell |
87,901
-1,333
| -1% | -$27.8K | ﹤0.01% | 2539 |
|
|
2016
Q1 | $2.41M | Buy |
89,234
+60,069
| +206% | +$1.72M | ﹤0.01% | 2246 |
|
|
2015
Q4 | $878K | Buy |
29,165
+17,488
| +150% | +$561K | ﹤0.01% | 2956 |
|
|
2015
Q3 | $369K | Buy |
11,677
+7,035
| +152% | +$257K | ﹤0.01% | 3526 |
|
|
2015
Q2 | $180K | Sell |
4,642
-3,339
| -42% | -$115K | ﹤0.01% | 3944 |
|
|
2015
Q1 | $281K | Buy |
7,981
+5,237
| +191% | +$169K | ﹤0.01% | 3613 |
|
|
2014
Q4 | $86K | Buy |
2,744
+2,606
| +1,888% | +$72.1K | ﹤0.01% | 4819 |
|
|
2014
Q3 | $3K | Buy |
138
+67
| +94% | +$1.34K | ﹤0.01% | 5616 |
|
|
2014
Q2 | $1K | Buy |
+71
| New | +$1.35K | ﹤0.01% | 5786 |
|
Other funds holding PAHC
VCM
VPM
N
Deutsche Bank's PAHC Position: Q1 2026 in Review
Deutsche Bank increased its Phibro Animal Health (PAHC) stake by 21% in Q1 2026, buying an estimated $145K and bringing the position to 17,822 shares worth $986K. The position accounts for ﹤0.01% of the portfolio, ranked #2185.
Deutsche Bank first reported a position in PAHC in Q2 2014 and has held it in 48 quarters since. The position peaked at $4.61M in Q1 2018. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- Deutsche Bank held 17,822 shares of Phibro Animal Health worth $986K as of Q1 2026.
- Deutsche Bank bought 3,055 Phibro Animal Health shares in Q1 2026, an estimated $145K.
- Phibro Animal Health made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2185 holding.
- Deutsche Bank first reported a position in Phibro Animal Health in Q2 2014 and has held it in 48 quarters since.
- Deutsche Bank's Phibro Animal Health position peaked at $4.61M in Q1 2018.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.